UnitedHealth Group (NYSE:UNH) Updates FY 2022 Earnings Guidance

UnitedHealth Group (NYSE:UNHGet Rating) updated its FY 2022 earnings guidance on Friday. The company provided earnings per share (EPS) guidance of $21.40-$21.90 for the period. The company issued revenue guidance of -.

Analyst Upgrades and Downgrades

Several equities analysts have weighed in on UNH shares. Morgan Stanley raised their price objective on UnitedHealth Group from $570.00 to $587.00 in a research note on Monday, July 18th. Deutsche Bank Aktiengesellschaft boosted their price objective on shares of UnitedHealth Group from $549.00 to $556.00 in a research note on Tuesday, July 19th. Sanford C. Bernstein lowered shares of UnitedHealth Group from an outperform rating to a market perform rating and set a $561.00 target price on the stock. in a report on Thursday, May 26th. They noted that the move was a valuation call. Truist Financial upped their price target on UnitedHealth Group from $575.00 to $610.00 in a research report on Thursday, April 7th. Finally, UBS Group upped their target price on UnitedHealth Group from $545.00 to $570.00 and gave the stock a neutral rating in a report on Thursday. Three research analysts have rated the stock with a hold rating, fifteen have issued a buy rating and two have assigned a strong buy rating to the stock. Based on data from MarketBeat.com, the stock currently has a consensus rating of Moderate Buy and a consensus target price of $578.95.

UnitedHealth Group Trading Down 0.2 %

NYSE:UNH opened at $521.41 on Monday. UnitedHealth Group has a 1 year low of $383.12 and a 1 year high of $553.29. The stock has a market cap of $489.17 billion, a price-to-earnings ratio of 27.23, a PEG ratio of 1.62 and a beta of 0.77. The business has a fifty day moving average of $497.56 and a 200-day moving average of $495.01. The company has a debt-to-equity ratio of 0.60, a quick ratio of 0.78 and a current ratio of 0.77.

UnitedHealth Group (NYSE:UNHGet Rating) last announced its earnings results on Friday, July 15th. The healthcare conglomerate reported $5.57 EPS for the quarter, beating the consensus estimate of $5.24 by $0.33. UnitedHealth Group had a return on equity of 25.45% and a net margin of 5.95%. The business had revenue of $80.33 billion during the quarter, compared to the consensus estimate of $79.68 billion. During the same period in the prior year, the business posted $4.70 earnings per share. UnitedHealth Group’s revenue was up 12.6% compared to the same quarter last year. Equities analysts predict that UnitedHealth Group will post 21.84 earnings per share for the current year.

UnitedHealth Group Increases Dividend

The firm also recently declared a quarterly dividend, which was paid on Tuesday, June 28th. Investors of record on Monday, June 20th were issued a dividend of $1.65 per share. This represents a $6.60 dividend on an annualized basis and a yield of 1.27%. This is a boost from UnitedHealth Group’s previous quarterly dividend of $1.45. The ex-dividend date was Thursday, June 16th. UnitedHealth Group’s dividend payout ratio (DPR) is currently 34.46%.

Insider Activity

In other UnitedHealth Group news, CEO Andrew Witty sold 11,376 shares of UnitedHealth Group stock in a transaction dated Monday, July 18th. The stock was sold at an average price of $527.90, for a total transaction of $6,005,390.40. Following the transaction, the chief executive officer now directly owns 76,559 shares in the company, valued at $40,415,496.10. The transaction was disclosed in a filing with the SEC, which is accessible through this hyperlink. In other UnitedHealth Group news, Director Richard T. Burke sold 2,500 shares of the company’s stock in a transaction on Monday, May 16th. The stock was sold at an average price of $493.25, for a total transaction of $1,233,125.00. Following the completion of the sale, the director now directly owns 1,220,000 shares in the company, valued at $601,765,000. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, CEO Andrew Witty sold 11,376 shares of the company’s stock in a transaction on Monday, July 18th. The stock was sold at an average price of $527.90, for a total transaction of $6,005,390.40. Following the transaction, the chief executive officer now owns 76,559 shares of the company’s stock, valued at $40,415,496.10. The disclosure for this sale can be found here. In the last ninety days, insiders sold 17,649 shares of company stock valued at $9,071,142. Company insiders own 0.40% of the company’s stock.

Hedge Funds Weigh In On UnitedHealth Group

Several large investors have recently added to or reduced their stakes in UNH. Charles Schwab Investment Management Inc. grew its stake in UnitedHealth Group by 2.6% in the 1st quarter. Charles Schwab Investment Management Inc. now owns 5,147,368 shares of the healthcare conglomerate’s stock valued at $2,625,004,000 after buying an additional 132,461 shares in the last quarter. Arrowstreet Capital Limited Partnership lifted its stake in UnitedHealth Group by 1,682.4% in the first quarter. Arrowstreet Capital Limited Partnership now owns 2,691,542 shares of the healthcare conglomerate’s stock worth $1,372,606,000 after purchasing an additional 2,540,538 shares during the last quarter. Capital Group Private Client Services Inc. lifted its stake in UnitedHealth Group by 1.2% in the first quarter. Capital Group Private Client Services Inc. now owns 524,057 shares of the healthcare conglomerate’s stock worth $267,253,000 after purchasing an additional 6,385 shares during the last quarter. Sculptor Capital LP increased its position in shares of UnitedHealth Group by 13.5% in the first quarter. Sculptor Capital LP now owns 498,807 shares of the healthcare conglomerate’s stock valued at $254,377,000 after acquiring an additional 59,359 shares during the period. Finally, Mariner LLC increased its position in shares of UnitedHealth Group by 15.3% in the first quarter. Mariner LLC now owns 423,948 shares of the healthcare conglomerate’s stock valued at $216,206,000 after acquiring an additional 56,195 shares during the period. Institutional investors own 87.48% of the company’s stock.

UnitedHealth Group Company Profile

(Get Rating)

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. It operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage and well-being services to individuals age 50 and older addressing their needs for preventive and acute health care services, as well as services dealing with chronic disease and other specialized issues for older individuals; Medicaid plans, children's health insurance and health care programs; health and dental benefits; and hospital and clinical services.

See Also

Earnings History and Estimates for UnitedHealth Group (NYSE:UNH)

Receive News & Ratings for UnitedHealth Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group and related companies with MarketBeat.com's FREE daily email newsletter.